Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD
This disclosure concerns the identification of genes with altered expression in patients with cancer-related fatigue (CRF) and their use in the diagnosis and treatment of patients with CRF.
BACKGROUND
Cancer-related fatigue (CRF) is a symptom experienced by cancer patients at all stages of
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a 35 U.S.C. .sctn. 371 National Phase Entry Application from PCT/KR2013/007852, filed on Aug. 30, 2013, and designating the United States, which is incorporated herein by reference in its entirety.
TECHNICAL FIELD
The present invention
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
This application is a U.S. national stage of PCT/EP2013/064711 filed on 11 Jul. 2013, which claims priority to and the benefit of Italian Application No. MI2012A001317 filed on 27 Jul. 2012, the contents of which are incorporated herein by reference in their entireties.
The present invention relates
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD
The invention concerns a method for the management of cancer and treatment cancer comorbidities, including but not limited to cancer-related fatigue, cachexia, anorexia, pain, anemia, asthenia, depression, impaired cognitive function, loss of appetite, muscle weakness, nausea,
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF INVENTION
The present invention relates to androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity, which are nonsteroidal ligands for the androgen receptor. The agents are useful for a) male contraception; b) treatment of a variety of hormone-related
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF INVENTION
The present invention relates to androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity, which are nonsteroidal ligands for the androgen receptor. The agents are useful for a) male contraception; b) treatment of a variety of hormone-related
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF INVENTION
The present invention relates to pharmaceutical compositions and formulations comprising a novel class of androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF INVENTION
The present invention relates to androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new subclass of compounds, which are selective androgen receptor modulators
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF INVENTION
The present invention relates to a novel class of androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new subclass of compounds, which are selective androgen receptor
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF INVENTION
The present invention relates to a novel class of androgen receptor targeting agents (ARTA), which are selective androgen receptor modulators (SARM). The SARM compounds are useful for a) male contraception; b) treatment of a variety of hormone-related conditions, for example
Database tanaman obat terlengkap yang didukung oleh sains
Bekerja dalam 55 bahasa
Pengobatan herbal didukung oleh sains
Pengenalan herbal melalui gambar
Peta GPS interaktif - beri tag herba di lokasi (segera hadir)
Baca publikasi ilmiah yang terkait dengan pencarian Anda
Cari tanaman obat berdasarkan efeknya
Atur minat Anda dan ikuti perkembangan berita, uji klinis, dan paten
Ketikkan gejala atau penyakit dan baca tentang jamu yang mungkin membantu, ketik jamu dan lihat penyakit dan gejala yang digunakan untuk melawannya. * Semua informasi didasarkan pada penelitian ilmiah yang dipublikasikan